Friday, July 27, 2012

A July 15 story about new treatments for hepatitis C misidentified one of two new drugs made available last year upon approval by the Food and Drug Administration. Victrelis is the trade name for boceprevir. Incivek is the trade name for telaprevir. Each drug may be used in combination with the older treatments, interferon and ribavirin.